Search details
1.
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
J Hepatol
; 81(1): 76-83, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38521170
2.
Low phospholipid-associated cholelithiasis syndrome (LPAC), a not uncommon cause of biliary problems and hospital admissions.
Rev Esp Enferm Dig
; 2024 Jun 14.
Article
in English
| MEDLINE | ID: mdl-38874003
3.
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
Hepatology
; 72(6): 1924-1934, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33022803
4.
[Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain]. / Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España.
Gastroenterol Hepatol
; 38(4): 263-73, 2015 Apr.
Article
in Spanish
| MEDLINE | ID: mdl-25583146
5.
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1.
Open Forum Infect Dis
; 6(5): ofz214, 2019 May.
Article
in English
| MEDLINE | ID: mdl-31139679
6.
Recovering from hepatorenal syndrome: reversibility of renal vasospasm demonstrated by Doppler ultrasound.
Nephron
; 90(4): 505-6, 2002 Apr.
Article
in English
| MEDLINE | ID: mdl-11961414
Results
1 -
6
de 6
1
Next >
>>